507 related articles for article (PubMed ID: 16447470)
21. Lung cancer risk prediction to select smokers for screening CT--a model based on the Italian COSMOS trial.
Maisonneuve P; Bagnardi V; Bellomi M; Spaggiari L; Pelosi G; Rampinelli C; Bertolotti R; Rotmensz N; Field JK; Decensi A; Veronesi G
Cancer Prev Res (Phila); 2011 Nov; 4(11):1778-89. PubMed ID: 21813406
[TBL] [Abstract][Full Text] [Related]
22. Screening for early lung cancer with low-dose spiral CT: prevalence in 817 asymptomatic smokers.
Diederich S; Wormanns D; Semik M; Thomas M; Lenzen H; Roos N; Heindel W
Radiology; 2002 Mar; 222(3):773-81. PubMed ID: 11867800
[TBL] [Abstract][Full Text] [Related]
23. Clinical and pathological profile of 73 patients with lung carcinoma: is the picture changing?
Chhajed PN; Athavale AU; Shah AC
J Assoc Physicians India; 1999 May; 47(5):483-7. PubMed ID: 10778555
[TBL] [Abstract][Full Text] [Related]
24. Screening for small-cell lung cancer: a follow-up study of patients with Lambert-Eaton myasthenic syndrome.
Titulaer MJ; Wirtz PW; Willems LN; van Kralingen KW; Smitt PA; Verschuuren JJ
J Clin Oncol; 2008 Sep; 26(26):4276-81. PubMed ID: 18779614
[TBL] [Abstract][Full Text] [Related]
25. Update on screening for lung cancer.
Midthun DE; Jett JR
Semin Respir Crit Care Med; 2008 Jun; 29(3):233-40. PubMed ID: 18506661
[TBL] [Abstract][Full Text] [Related]
26. Screening for early lung cancer with low-dose spiral computed tomography: results of annual follow-up examinations in asymptomatic smokers.
Diederich S; Thomas M; Semik M; Lenzen H; Roos N; Weber A; Heindel W; Wormanns D
Eur Radiol; 2004 Apr; 14(4):691-702. PubMed ID: 14727146
[TBL] [Abstract][Full Text] [Related]
27. Usefulness of FDG-PET/CT in the detection of pancreatic metastases from lung cancer.
Sato M; Okumura T; Kaito K; Kiyoshima M; Asato Y; Uchiumi K; Iijima H; Hashimoto I; Kaburagi T; Amemiya R
Ann Nucl Med; 2009 Jan; 23(1):49-57. PubMed ID: 19205838
[TBL] [Abstract][Full Text] [Related]
28. Lung cancer in transplant recipients: a single-institution experience.
Ahmed Z; Marshall MB; Kucharczuk JC; Kaiser LR; Shrager JB
Arch Surg; 2004 Aug; 139(8):902-6. PubMed ID: 15302702
[TBL] [Abstract][Full Text] [Related]
29. Screening for lung cancer in high-risk groups: current status of low-dose spiral CT scanning and sputum markers.
Jett JR
Semin Respir Crit Care Med; 2000; 21(5):385-92. PubMed ID: 16088750
[TBL] [Abstract][Full Text] [Related]
30. Screening for lung cancer: New horizons?
Rossi A; Maione P; Colantuoni G; Gaizo FD; Guerriero C; Nicolella D; Ferrara C; Gridelli C
Crit Rev Oncol Hematol; 2005 Dec; 56(3):311-20. PubMed ID: 15978829
[TBL] [Abstract][Full Text] [Related]
31. Lung cancer screening: a different paradigm.
McWilliams A; Mayo J; MacDonald S; leRiche JC; Palcic B; Szabo E; Lam S
Am J Respir Crit Care Med; 2003 Nov; 168(10):1167-73. PubMed ID: 12882756
[TBL] [Abstract][Full Text] [Related]
32. Screening for lung cancer--a review.
Kuzniar T; Masters GA; Ray DW
Med Sci Monit; 2004 Feb; 10(2):RA21-30. PubMed ID: 14737058
[TBL] [Abstract][Full Text] [Related]
33. Lung cancer screening with CT: Mayo Clinic experience.
Swensen SJ; Jett JR; Hartman TE; Midthun DE; Sloan JA; Sykes AM; Aughenbaugh GL; Clemens MA
Radiology; 2003 Mar; 226(3):756-61. PubMed ID: 12601181
[TBL] [Abstract][Full Text] [Related]
34. Histologic types, staging, resectability, and smoking among Thai patients with lung cancer.
Riantawan P; Tungsagunwattana S; Subhannachart P; Yodtasurodom C
J Med Assoc Thai; 1999 Feb; 82(2):121-5. PubMed ID: 10087718
[TBL] [Abstract][Full Text] [Related]
35. Lung cancer screening with low-dose computed tomography: Canadian experience.
Roberts HC; Patsios D; Paul NS; McGregor M; Weisbrod G; Chung T; Herman S; Boerner S; Waddell T; Keshavjee S; Darling G; Pereira A; Kale A; Bayanati H; Sitartchouk I; Tsao M; Shepherd FA
Can Assoc Radiol J; 2007 Oct; 58(4):225-35. PubMed ID: 18186434
[TBL] [Abstract][Full Text] [Related]
36. Lung cancer after heart transplantation: a 17-year experience.
Potaris K; Radovancevic B; Thomas CD; Gregoric I; Vaporciyan AA; Riggs SA; Radovancevic R; Vaughn WK; Frazier OH
Ann Thorac Surg; 2005 Mar; 79(3):980-3. PubMed ID: 15734418
[TBL] [Abstract][Full Text] [Related]
37. A quantitative method for estimating individual lung cancer risk.
Avila RS; Zulueta JJ; Shara NM; Jansen K; Veronesi G; Wang H; Mulshine JL
Acad Radiol; 2010 Jul; 17(7):830-40. PubMed ID: 20540908
[TBL] [Abstract][Full Text] [Related]
38. Incidence and clinical characteristics of symptomatic choroidal metastasis from lung cancer.
Kreusel KM; Bechrakis NE; Wiegel T; Krause L; Foerster MH
Acta Ophthalmol; 2008 Aug; 86(5):515-9. PubMed ID: 18081901
[TBL] [Abstract][Full Text] [Related]
39. The outcome differences of CT screening for lung cancer pre and post following an algorithm in Zhuhai, China.
Liu X; Liang M; Wang Y; Chen K; Chen X; Qin P; He J; Yi X
Lung Cancer; 2011 Aug; 73(2):230-6. PubMed ID: 21168238
[TBL] [Abstract][Full Text] [Related]
40. Lung cancer histopathology in the Thrace region of Turkey and comparison with national data.
Karlikaya C; Cakir Edis E
Tuberk Toraks; 2005; 53(2):132-8. PubMed ID: 16100649
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
